AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIO-TECHNE Corp Director's Dealing 2010

May 3, 2010

30718_dirs_2010-05-03_8af5403d-8b26-40bd-9233-91351ee5b83d.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (tech)
CIK: 0000842023
Period of Report: 2010-04-30

Reporting Person: MELSEN GREGORY J (VP Finance and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-04-30	Employee Stock Option	$66.25	A	30000	Acquired	2017-04-29	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	542	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option	$62.46	2016-07-23	Common Stock (203)	203	Direct
Employee Stock Option	$79.41	2008-07-24	Common Stock (596)	596	Direct
Employee Stock Option	$56.83	2014-07-26	Common Stock (783)	783	Direct
Employee Stock Option	$49.43	2013-07-26	Common Stock (1012)	1012	Direct
Employee Stock Option	$51.6	2012-08-17	Common Stock (426)	426	Direct
Employee Stock Option	$39.53	2014-12-16	Common Stock (25000)	25000	Direct

Footnotes

F1: Vesting: 7500 each 4/30/11; 4/30/12; 4/30/13; 4/30/14